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Abstract
Background: Objective markers of early airway inflammation in infants are not established but are of great interest
in a scientific setting. Exhaled nitric oxide (FeNO) and urinary eosinophilic protein X (uEPX) are a two such
interesting markers.
Objective: To investigate the feasibility of measuring FeNO and uEPX in infants and their mothers and to
determine if any relations between these two variables and environmental factors can be seen in a small sample
size. This was conducted as a pilot study for the ongoing Swedish Environmental Longitudinal Mother and child
Asthma and allergy study (SELMA).
Methods: Consecutive infants between two and six months old and their mothers at children’s health care centres
were invited, and 110 mother-infant pairs participated. FeNO and uEPX were analysed in both mothers and infants.
FeNO was analyzed in the mothers online by the use of the handheld Niox Mino device and in the infants offline
from exhaled air sampled during tidal breathing. A 33-question multiple-choice questionnaire that dealt with
symptoms of allergic disease, heredity, and housing characteristics was used.
Results: FeNO levels were reduced in infants with a history of upper respiratory symptoms during the previous
two weeks (p < 0.002). There was a trend towards higher FeNO levels in infants with windowpane condensation in
the home (p < 0.05). There was no association between uEPX in the infants and the other studied variables.
Conclusion: The use of uEPX as a marker of early inflammation was not supported. FeNO levels in infants were
associated to windowpane condensation. Measuring FeNO by the present method may be an interesting way of
evaluating early airway inflammation. In a major population study, however, the method is difficult to use, for
practical reasons.
Keywords: Nitric Oxide Eosinophil Granule Proteins, Infant, Housing, Allergy and Immunology
Background
Asthma and allergic diseases in children are important
public health problems, but they are not fully under-
stood from an aetiological point of view. Allergic dis-
eases usually start in early childhood with food allergies
and atopic dermatitis, followed by asthma and rhinitis.
These conditions are usually diagnosed in a clinical set-
ting when they are manifest. However, there is a strong
need for early and objective markers of preclinical dis-
ease, as eosinophilic inflammation, both in clinical and
scientific settings.
Foetal environment and early life factors are suggested
to programme risk of allergic disease in later life. The
study Dampness in Buildings and Health (DBH) showed
that asthma and allergies among children are associated
with exposure to chemicals such as phthalates from
plasticized Poly Vinyl Chloride (PVC), organic com-
pounds associated with cleaning products, and a low
ventilation rate in the house [1].
In 1993 it was found that FeNO is elevated in
patients with asthma [2]. Since then, measuring FeNO
has become a widely used method for evaluating eosi-
nophilic inflammation in the airways among asthmatics
[3]. FeNO has also been shown to be raised in infants
at increased risk of developing asthma, with a strong
correlation to atopic disease and maternal smoking
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reproduction in any medium, provided the original work is properly cited.[4,5]. Recently, increased FeNO in one-month-old
infants has been shown to predispose to transient
early wheeze and recurrent wheeze in the first year of
life [6].
Ambient NO mostly affects nasal NO levels, though
an association with FeNO has been found in infants [7].
Ongoing or recent airway infections may elevate the
FeNO levels, while smoking is known to lower FeNO
levels, due to airway epithelial changes [8,9]. Today,
there is no standardized method for the measurement of
FeNO in infants. Single-breath exhalation, the recom-
mended technique for youths and adults, requires coop-
eration and is not suitable for infants.
Urinary eosinophilic protein X (uEPX) is a cationic
protein, also called eosinophil derived neurotoxin, that
is released by eosinophils and can be detected in urine.
Urinary EPX levels are known to correlate to eosinophi-
lic inflammation in the lungs, measured by bronchoal-
veolar eosinophilic cell count [10]. In 3-year-old
children, uEPX has been shown to be associated with
atopy and allergy-related symptoms [11]. Moreover, it
has been shown to predict persistent asthma, and to
predict allergic sensitization in children [12]. It shows a
circadian rhythm with the highest levels occurring at
night, and sampling should therefore be carried out at
the same time of day [13].
A positive correlation between FeNO and uEPX has
been shown in asthmatic children [14] although more
recent data has not confirmed this observation [15]. In
children with atopic dermatitis, uEPX levels have been
shown to correlate to the severity of disease [16] and
have been suggested to be useful for monitoring the
progression of allergic disease [11].
Prospective cohort studies with a mother-child design
are necessary to better understand the contributing
environmental factors. The aim of the present pilot
study was to investigate the feasibility of measuring
FeNO and uEPX in infants up to six months of age.
Furthermore, the study aimed to examine relations
between indoor environmental factors and these two
biomarkers of inflammation.
Methods
General design
The Swedish Environmental Longitudinal Mother and
child Asthma and allergy study (SELMA), is an ongoing
prospective mother-child study in which exposure to
environmental factors during the period of pregnancy
and infancy are investigated for their role in the devel-
opment of asthma and allergies in children (http://www.
selmastudy.se). In this type of cohort study of a whole
population, it is important to find non-invasive biomar-
kers for early disease. For practical reasons two different
types of bio-markers, one sampled in exhaled air and
one in a collected urine sample, were chosen for the
present study.
The study was performed at three children’sh e a l t h
care centres in Värmland, Sweden. Consecutive infants
and their mothers who were scheduled for a regular
visit at the age of two or six months were invited to par-
ticipate with a letter sent to the parents. This included a
description of the study, an informed consent form,
materials and instructions for urine sampling, and a
questionnaire. The mothers were asked 33 multiple-
choice questions focusing on symptoms of allergic dis-
ease, heredity and housing characteristics. The question-
naire has been validated in an earlier study [1]. This
validation showed that PVC flooring is often mistaken
for “cork-o-plast” flooring, and that the latter has never,
or almost never, been laid in Swedish bedrooms. Data
for body weight and body length were collected upon
examination and asked for from the mothers.
Measurement of exhaled NO
FeNO measurements were performed for the mother
online with the handheld device NIOX MINO (Aero-
crine AB, Stockholm, Sweden) with a detection limit of
5 ppb. This method is in accordance with the American
Thoracic Society (ATS) recommendations for online
NO measurement [3,17].
For analysis of FeNO-levels in infants, there is no
standardized method. In the present study mixed oral/
nasal FeNO was measured off-line during tidal breathing
with an unseptated face mask (Hans Rudolph Inc) cov-
ering the nose and mouth as described by Gabriele et al
[18]. Sampling took place during a regular visit at the
children’s health care centre. Exhaled air was sampled if
the unsedated infant succeeded in breathing quietly for
at least five breaths into the face mask that was tightly
fitted during the whole procedure. No correction for
flow was made. Ambient NO was measured before each
sampling and no NO-free air was available. FeNO-mea-
surements where ambient NO was > 5 ppb were
excluded in order to avoid interactions. Exhaled air was
sampled in an inert mylar balloon via a non re-breathing
valve. The NO concentration in the exhaled air was
measured off-line within 24 hours with the CLD 77 AM
nitric oxide chemiluminiscence analyser (ECO-physics
GmBH, Dürnten, Switzerland).
Urinary sampling
Urine from the infant was collected by the parents by
means of sanitary towels made of cellulose tissue put
into the regular diaper on the night before the visit. The
test kit included plastic gloves that were used to squeeze
the sanitary towels for the urine, which was subse-
quently collected in laboratory sampling tubes. All tubes
were kept cold and were frozen within 24 hours.
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Urinary EPX was analysed with an ELISA immunoas-
say, manufactured by Diagnostics Development,
Uppsala, Sweden. The assay was run according to
the manufacturer’s instructions. In order to minimize
the influence of differences in water dilution, uEPX
levels were adjusted by the creatinine concentration
(uEPX/c).
Statistical methods
The uEPX/creatinine quotient values were skewly dis-
tributed and log-transformed prior to analysis. FeNO
levels in both the mothers and the infants were non-
normally distributed and the distributions were not cor-
rected by log-transformations. Urinary EPX levels in
both the mothers and the infants were non-normally
distributed, but corrected by log-transformation.
For normally distributed data, unpaired t-test was
used for comparisons between groups. For non-nor-
mally distributed data, Mann-Whitney U test was used
for differences between groups. Spearman’s correlation
test was used for correlation analyses. A p-value below
0.05 was considered statistically significant. Values are
presented as median, range and interquartile range
(IQR). Statistic analysis was performed using SPSS 15.0
for Windows.
The project was approved by the regional ethics com-
mittee (Uppsala, Sweden) and written informed consent
was obtained from all the participating parents.
Results
Invitation letters were sent to 209 mother-child pairs,
110 (52%) of which agreed to participate. Of the 110
children in the study, 53 (48%) were girls, 51 (46%) were
six months old, and 56 (51%) were two months old.
Twelve of the infants were reported as having a cold
at the time of the examination or during the two weeks
immediately prior. Eight of the children (7%) were
reported as being exposed to tobacco-smoke, either
presently or during pregnancy. Furred pets were kept
in the homes of 53 (49%) of the infants. Windowpane
condensation of any degree was reported in 30% of the
homes.
FeNO levels
FeNO levels in both the mothers and the infants were
non-normally distributed and the distribution was not
corrected by log-transformation. The FeNO levels were
significantly higher in those infants with reported upper
respiratory symptoms (URS), such as rhinorrhoea, in the
immediately preceding two weeks (p < 0.002, table 1
and figure 1). No such difference was found in the
mothers. In the further analyses, FeNO levels of infants
and mothers with URS were excluded.
FeNO infants, n = 98
The participants were fairly evenly distributed between
living in the town centres, suburbs, or countrysides of
either Karlstad (90,000 inhabitants) or Filipstad (11,000
inhabitants). About half of the infants were reported to
have wooden flooring in their bedrooms. Housing char-
acteristics of the participants are presented in table 2.
In all instances ambient NO was low, below 10 ppb.
However, at the time of four samplings made on the
same day at the same location, ambient NO was found
to be more than 5 ppb and these FeNO values were
excluded.
No significant correlations were found between FeNO
in the infants and weight, weight at birth, age, length,
uEPX levels, family size, or FeNO levels of the mothers.
As seen in table 3, there was a trend towards higher
FeNO levels in infants with parent-reported window-
pane condensation in the living room (p < 0.05, figure 2),
in the parents’ bedroom (p = 0.06), and in the infant’s
b e d r o o m( p=0 . 1 0 ) .M o r e o v e r ,t h e r ew a sat r e n d
towards lower FeNO-levels in infants from larger homes
(p = 0.07, r2 = -0.2).
There was no significant difference in FeNO levels
between different flooring materials in the homes, her-
edity for allergic disease, tobacco-smoke exposition,
reported wheezing, or presence of furred pets in the
homes.
FeNO mothers
FeNO levels were significantly (p < 0.04) higher in sub-
jects living in flats (n 42, median 12, IQR 10) compared
to other types of dwelling (n 50, median 8, IQR 7).
There was a trend towards lower FeNO-levels in
subjects living in larger homes.
There was no significant difference in FeNO levels
between mothers with or without asthma, but mothers
with reported allergic rhino-conjunctivits (n 24, median
14.0, IQR 14.0) had significantly higher FeNO levels (p
< 0.004) than those without (n 68, median 8.0, IQR 9.0).
A majority of the measurements were made during the
pollen-season. No difference was found in FeNO levels
in the mothers related to occurrence of windowpane
condensation.
Table 1 Median FeNO levels (ppb) in relation to upper
respiratory symptoms (URS) in the previous two weeks
N Median Range IQR
Infants with URS 10 7.0 2-37 5.4
Infants without URS 88 15.0 2-47 8.6
Infants, all 98 14.4 2-47 9.4
Mothers with URS 12 13.0 5-59 9.0
Mothers without URS 92 9.0 5-67 9.0
Mothers, all 104 9.0 5-67 9.0
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There was no difference in EPX levels between infants
or mothers with or without reported symptoms of URS
during the preceding two weeks (table 4).
EPX infants
There was no difference in uEPX/c levels in infants with
a history of wheezing, eczema, exposure to tobacco
smoke, or atopic heredity. Moreover, there was no sig-
nificant correlation to body weight, length, or FeNO-
levels. EPX levels were significantly higher in infants
with reported PVC flooring in their bedrooms. However,
when “cork-o-plast” flooring (n = 7) was included in the
PVC-group no significance was found.
EPX mothers
As shown in table 5, the uEPX levels were higher
in mothers with self-reported asthma (p = 0.09), aller-
gic rhino-conjunctivitis (p < 0.05) and any allergic
disease (p < 0.03). Otherwise no significant differences
or correlations with the evaluated parameters were
found.
Discussion
The present pilot study investigated the usefulness of
two non-invasive methods, FeNO and uEPX measure-
ment, for the evaluation of airway inflammation in
infants and their mothers.
The present data support the conclusion that the
method used to analyse FeNO in infants may be suitable
for a major population study. There was an association
between windowpane condensation and elevated levels
of FeNO among the infants. Moreover, uEPX was
elevated in infants with reported PVC flooring in their
bedrooms, and both results may indicate an early proin-
flammatory effect of indoor air emissions. However,
since “cork-o-plast” flooring has never been used in bed-
r o o m si nS w e d i s hh o m e sa n di so f t e nc o n f u s e dw i t h
Figure 1 Reported occurrence of reported upper respiratory symptoms in the preceding two weeks and FeNO levels in the infants,
circles indicate outliers
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group, which undermined the relation.
Subjects were recruited among healthy infants in chil-
dren’s health care centres, at a young age. Hence, only a
minority has atopic heredity and only a few of the study
subjects will develop respiratory disease. This, together
with the small sample size, reduces the power of the
study.
The method used for measuring FeNO in infants has
been criticized for non-accuracy, but in this setting we
found a reasonable range and median levels in parity
with the mothers. The evident lowering of FeNO levels
in those infants with reported upper airway infections is
in accordance with what could be expected. This is
probably due to less breathing through the nose, making
the exhaled air consist of less air affected by the NO-
rich nasal cavity. Indeed, it has previously been reported
that FeNO levels are reduced in infants with rhinorrhea
[19] and URS [4,20]. Despite its large variation, ambient
NO has been shown to have little effect on FeNO. The
currently recommended technique, which includes inha-
lation through an NO scrubber, effectively deals with
the effect of variable levels of ambient NO on FeNO. In
contrast, ambient NO has an effect on measurements of
nasal NO when measured with another sampling techni-
que [7]. In the present study nasal NO may influence
the FeNO levels due to the sampling technique, and
subjects with more than 5 ppb ambient NO at the time
of the sampling were therefore excluded from the FeNO
analyses. However, when these four subjects were
included in the analyses, the reported correlations were
strengthened.
The positive correlation between FeNO in the infants
and windowpane condensation is in accordance with
previous findings among 374 schoolchildren [21]. In
that study, those who were non-sensitized to airway
allergens and lived in homes with windowpane conden-
sation were found to have higher FeNO levels. Window
condensation, as a measure of building dampness, has
also been found to be associated with an increase of
asthma in preschool children [22].
One could speculate that dampness in buildings could
be associated with an altered nasal flow. However, in a
study performed among schoolchildren [21], the same
association between windowpane condensation and ele-
vated FeNO-levels was found, despite the use of only
orally exhaled air.
The trend in the present study that FeNO levels are
lower in infants living in larger homes is also seen
among the mothers. Living in a larger home is about
the same as living in a detached house, and correspond-
ingly lower FeNO levels were seen among mothers liv-
ing in detached houses, although the same was not the
case among the children. Several confounders, such as
socio-economic factors and type of ventilation, could be
involved in this correlation.
In the cross-sectional DBH study of 10,000 children in
Sweden it was shown that reported dampness in the
homes is a risk factor for asthma and allergic symptoms
among preschool children [23]. The present findings
indicate an early influence of dampness in the home on
FeNO-levels in infancy. Thus, measuring FeNO by the
present method may be an interesting non-invasive way
of evaluating early inflammation in the airways. In a
major population study, however, the measurement of
FeNO would have to be centralized and would therefore
not be suitable for a study design using the everyday
Table 2 Housing characteristics of 98 infants
Answer N (%)
Any smoker in the home Yes 12(12)
Smoking mother during pregnancy Yes 5 (5)
Exposure to tobacco smoke during or after
pregnancy
Yes 8 (8)
Windowpane condensation, any amount, in the
home
Yes 29
(30)
Type of flooring in the infant’s bedroom PVC 27
(28)
Wood 50
(51)
Other 21
(21)
Location of the home Town centre 33
(34)
Suburb 38
(39)
Countryside 26
(27)
Size of the home <75 m
2 17
(17)
75-99 m
2 31
(32)
>100 m
2 50
(51)
Type of home Apartment 42
(43)
Row house 8 (8)
Detached
house
48
(49)
Table 3 Median levels of FeNO (ppb) in the infants in
relation to parental reported occurrence of window pane
condensation
Yes/no N Median Range IQR
Living room? No 57 14.6 2.1-35.0 7.5
Yes 17 19.0 2.4-47.0 10.4
Parents’ bedroom? No 51 14.6 4.2-35.0 7.5
Yes 24 18.4 2.1-47.0 10.3
Infant’s bedroom? No 54 14.8 2.1-35.0 7.6
Yes 19 18.0 2.4-47.0 10.6
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because the balloons must be transported to the labora-
tory for analysis within 24h. Moreover, 34 children’s
health care centres are involved in the study and the
sampling of the exhaled air is not easily standardized
with several performers.
The analysis of uEPX/c in the present study may be
questioned due to the sampling method, because this
cationic protein adheres to the structures in the sanitary
towel. In our own analysis of five healthy volunteers, we
found a marked decrease in urinary EPX/c levels after
incubation of urine in the sanitary towel. However, this
systematic decrease may be of less relevance in a major
setting. No normal values are established, but the uEPX/
c levels were found to be of about the same magnitude
in both the mothers and the children although the sam-
pling method differed between these groups.
No association was found between uEPX/c levels and
FeNO, as has been found in previous studies of asth-
matic children [24]. The present study subjects are
probably too young to have developed any eosinophilic
inflammation in the airways. The association in the
mothers between allergic symptoms and uEPX/c levels
are in accordance with previous findings.
Figure 2 Reported occurrence of windowpane condensation in the living room and FeNO levels in the infants, circles indicate outliers.
Table 4 Median levels of uEPX/c (mg/mol creatinine) in
the infants and the mothers
N Median Range IQR
Infants 86 21.4 7.1-81.1 15.5
Mothers 86 20.7 3.6-94.0 16.6
Table 5 Median levels of uEPX/c (mg/mol creatinine) in
the mothers related to reported allergic disease
Yes/no N Median Range IQR
Asthma? No 76 20.4 3.6-94.0 16.0
Yes 9 23.4 18.3-57.8 29.0
Rhino-conjunctivitis? No 59 19.2 3.6-66.1 16.8
Yes 27 21.9 7.9-94.0 17.1
Any allergic disease? No 53 16.8 3.6-66.1 16.3
Yes 32 22.6 7.9-94.0 16.0
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In the present setting, samples were taken during the
first six months of life and few reports of wheezing and
allergic symptoms occurred. Urinary EPX may be useful
as a non-invasive early marker of inflammation, but in
this study and with this sampling method, nothing sup-
ports the use of urinary EPX in a major study such as
SELMA. FeNO levels in infants were associated to
building dampness, measured as windowpane condensa-
tion. Measuring FeNO by the present method may be
an interesting non-invasive way of evaluating early
inflammation in the airways.
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